Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of Foscarnet

A new enzyme-labile group called S-acyl-3-thiopropyl group (SATP) has been synthesized from allylic esters of phosphonate. After demonstration of the enzyme-labile character of the SATP in cellular extracts, it has been introduced onto the phosphonate moiety of PFA (Foscarnet) to obtain potential li...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 12; no. 6; pp. 1393 - 1402
Main Authors Gagnard, Valérie, Leydet, Alain, Morère, Alain, Montero, Jean-Louis, Lefèbvre, Isabelle, Gosselin, Gilles, Pannecouque, Christophe, De Clercq, Erick
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 15.03.2004
Elsevier Science
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new enzyme-labile group called S-acyl-3-thiopropyl group (SATP) has been synthesized from allylic esters of phosphonate. After demonstration of the enzyme-labile character of the SATP in cellular extracts, it has been introduced onto the phosphonate moiety of PFA (Foscarnet) to obtain potential lipophilic prodrugs. To ponder the lipophilicity of the triesters of PFA, esters of monomethylether of polyethyleneglycols and of thioglycerol were introduced on the PFA carboxylate moiety. The SATP groups were introduced in an attempt to deliver PFA after bioactivation inside the cells. The PFA prodrugs were evaluated in vitro for their activity against human immunodeficiency viruses (HIV-1 and HIV-2). The PFA prodrugs were evaluated in vitro for their activity against human immunodeficiency viruses (HIV-1 and HIV-2).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2004.01.017